Skip to main content

Table 1 Patient characteristics and risk factors in the study groups

From: Periprocedural and clinical outcomes of percutaneous coronary intervention of chronic total occlusions in patients with low- and mid-range ejection fractions

Variable

G (N) (nom. = 25)

G (M) (nom. = 25)

G (L) (nom. = 25)

p value

Age (years) (mean ± SD)

60.40 ± 8.37

60.042 ± 7.91

61.07 ± 8.24

0.901

BMI (kg/m2) (mean ± SD)

27.69 ± 2.44

27.81 ± 2.21

27.58 ± 1.64

0.928

CKD (nom. (%))

3 (12%)

5 (20%)

12 (48%)

0.01*

DM (nom. (%))

7 (28%)

8 (32%)

15 (60%)

0.042*

Dyslipidemia (nom. (%))

14 (56%)

16 (64%)

17 (68%)

0.671

Hypertension (nom. (%))

20 (80%)

18 (72%)

20 (80%)

0.738

Male (nom. (%))

21 (84%)

20 (80%)

19 (76%)

0.779

Post CABG (nom. (%))

3 (12%)

5 (20%)

4 (16%)

0.743

Prior PCI (nom. (%))

8 (32%)

10 (40%)

5 (20%)

0.304

Smoking (nom. (%))

16 (64%)

17 (68%)

20 (80%)

0.433

  1. Data are expressed as mean ± SD or number (%)
  2. BMI: body mass index, CABG: coronary artery bypass graft, CKD: chronic kidney disease, DM: diabetes mellitus, G (N): normal LVEF group, G (M): mid-range LVEF group, G (L): low LVEF group, *:significant